Existing treatments have limited success, and tumor recurrence is common. Oncolytic viruses—viruses that selectively target ...

A team led by researchers at Penn State College of Medicine has now re-engineered immune cells so that they can penetrate and kill solid tumors grown in the lab. The scientists created a light ...

CNSide CSF Assay evaluated 258 CSF samples across 66 patients with LM to analyze clinically ... longer and partly because many standard chemotherapies cannot reach sufficient concentrations in the ...